$CNMD
CONMED Corp Stock $cnmd

$cnmd Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000081695613000006 Filed on April 29, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$187.0M	$194.3M
YoY Change	-3.76%	5.92%
Cost Of Revenue	$84.33M	$93.41M
YoY Change	-9.71%	6.46%
Gross Profit	$102.7M	$100.9M
YoY Change	1.76%	5.43%
Gross Profit Margin	54.91%	51.93%
Selling, General & Admin	$77.73M	$74.81M
YoY Change	3.9%	6.75%
% of Gross Profit	75.69%	74.13%
Research & Development	$5.694M	$7.095M
YoY Change	-19.75%	-7.63%
% of Gross Profit	5.55%	7.03%
Depreciation & Amortization	$4.619M	$4.688M
YoY Change	-1.47%	6.16%
% of Gross Profit	4.5%	4.65%
Operating Expenses	$86.81M	$83.89M
YoY Change	3.48%	6.93%
Operating Profit	$15.87M	$17.02M
YoY Change	-6.77%	-1.4%
Interest Expense	$1.366M	$1.437M
YoY Change	-4.94%	-20.39%
% of Operating Profit	8.61%	8.44%
Other Income/Expense, Net
YoY Change
Pretax Income	$14.24M	$15.59M
YoY Change	-8.62%	8.5%
Income Tax	$3.749M	$5.617M
% Of Pretax Income	26.33%	36.04%
Net Earnings	$10.49M	$9.968M
YoY Change	5.26%	10.82%
Net Earnings / Revenue	5.61%	5.13%
Basic Earnings Per Share	$0.37	$0.36
Diluted Earnings Per Share	$0.37	$0.35
COMMON SHARES
Basic Shares Outstanding	28.13M shares	28.03M shares
Diluted Shares Outstanding	28.50M shares	28.48M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$32.40M	$19.50M
YoY Change	66.15%	8.94%
Cash & Equivalents	$32.36M	$19.45M
Short-Term Investments
Other Short-Term Assets	$27.20M	$26.10M
YoY Change	4.21%	20.83%
Inventory	$156.9M	$163.4M
Prepaid Expenses
Receivables	$135.6M	$142.4M
Other Receivables	$2.000M	$0.00
Total Short-Term Assets	$354.0M	$351.3M
YoY Change	0.77%	-1.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$138.4M	$141.0M
YoY Change	-1.86%	-0.05%
Goodwill	$249.2M	$234.8M
YoY Change	6.12%
Intangibles	$188.8M	$193.6M
YoY Change	-2.5%
Long-Term Investments
YoY Change
Other Assets	$152.6M	$155.8M
YoY Change	-2.05%	1473.74%
Total Long-Term Assets	$729.0M	$725.3M
YoY Change	0.51%	14.33%
TOTAL ASSETS
Total Short-Term Assets	$354.0M	$351.3M
Total Long-Term Assets	$729.0M	$725.3M
Total Assets	$1.083B	$1.077B
YoY Change	0.6%	8.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.05M	$27.09M
YoY Change	-7.54%	12.4%
Accrued Expenses	$24.50M	$20.90M
YoY Change	17.22%	-1.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.050M	$54.22M
YoY Change	-98.06%	-51.37%
Total Short-Term Liabilities	$97.18M	$165.8M
YoY Change	-41.41%	-8.12%
LONG-TERM LIABILITIES
Long-Term Debt	$224.8M	$139.0M
YoY Change	61.78%	93.53%
Other Long-Term Liabilities	$61.23M	$89.25M
YoY Change	-31.39%	214.25%
Total Long-Term Liabilities	$286.0M	$228.2M
YoY Change	25.34%	127.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$97.18M	$165.8M
Total Long-Term Liabilities	$286.0M	$228.2M
Total Liabilities	$485.4M	$489.8M
YoY Change	-0.9%	25.15%
SHAREHOLDERS EQUITY
Retained Earnings	$384.2M	$360.2M
YoY Change	6.67%
Common Stock	$313.0K	$313.0K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$86.05M	$71.99M
YoY Change	19.53%
Treasury Stock Shares
Shareholders Equity	$597.6M	$586.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.083B	$1.077B
YoY Change	0.6%	8.48%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	$10.49M	$9.968M
YoY Change	5.26%	10.82%
Depreciation, Depletion And Amortization	$4.619M	$4.688M
YoY Change	-1.47%	6.16%
Cash From Operating Activities	$5.472M	$7.629M
YoY Change	-28.27%	-63.14%
INVESTING ACTIVITIES
Capital Expenditures	$4.130M	$6.424M
YoY Change	-35.71%	55.06%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$64.10M
YoY Change	-100.0%	64000.0%
Cash From Investing Activities	-$4.130M	-$70.54M
YoY Change	-94.15%	1573.55%
FINANCING ACTIVITIES
Cash Dividend Paid		$4.300M
YoY Change
Common Stock Issuance & Retirement, Net	$25.73M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$7.634M	$55.82M
YoY Change	-86.32%	-576.53%
NET CHANGE
Cash From Operating Activities	$5.472M	$7.629M
Cash From Investing Activities	-$4.130M	-$70.54M
Cash From Financing Activities	$7.634M	$55.82M
Net Change In Cash	$8.976M	-$7.095M
YoY Change	-226.51%	-248.68%
FREE CASH FLOW
Cash From Operating Activities	$5.472M	$7.629M
Capital Expenditures	$4.130M	$6.424M
Free Cash Flow	$1.342M	$1.205M
YoY Change	11.37%	-92.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	25045000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	23622000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	139124000	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	135597000	USD
CY2013Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2100000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2706000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27581000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-26699000	USD
CY2013Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P29Y
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	324322000	USD
CY2013Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	325801000	USD
CY2013Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7110000	USD
CY2012Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7124000	USD
CY2012Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1932000	USD
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1988000	USD
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	400000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2013Q1	us-gaap	Assets Assets	1082985000	USD
CY2012Q4	us-gaap	Assets Assets	1079507000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	353998000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	348893000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23720000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32359000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26048000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19454000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8639000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6594000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2013Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31299194	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31299194	shares
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	313000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	313000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11374000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11045000	USD
CY2012Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	93405000	USD
CY2013Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	84332000	USD
CY2012Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2735000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1914000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	11931000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	10703000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1188000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1057000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	99857000	USD
CY2013Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	102199000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-732000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-732000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	7500000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	1131000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	1319000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	859000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	769000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	250000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	525000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	65000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	68000	USD
CY2012Q1	us-gaap	Depreciation Depreciation	4688000	USD
CY2013Q1	us-gaap	Depreciation Depreciation	4619000	USD
CY2013Q1	us-gaap	Derivative Assets DerivativeAssets	2452000	USD
CY2012Q4	us-gaap	Derivative Assets DerivativeAssets	457000	USD
CY2013Q1	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	1510000	USD
CY2012Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	-1942000	USD
CY2013Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	942000	USD
CY2012Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2399000	USD
CY2012Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4328000	USD
CY2013Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4189000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-337000	USD
CY2012Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	501000	USD
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	24538000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33511000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	87637000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	89625000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7115000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	7731000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6550000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6608000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6619000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6721000	USD
CY2013Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1500000	USD
CY2012Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	400000	USD
CY2013Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-263000	USD
CY2012Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2013Q1	us-gaap	Goodwill Goodwill	249160000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	249160000	USD
CY2013Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-7661000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	102682000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	100911000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	14241000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15585000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3749000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5617000	USD
CY2013Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2000000	USD
CY2012Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2897000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	313000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2601000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5618000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3042000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1232000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	244000	USD
CY2012Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-10446000	USD
CY2013Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-8830000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2764000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4858000	USD
CY2012Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2339000	USD
CY2013Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	5020000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2423000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1106000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-5032000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-7566000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	190809000	USD
CY2013Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	188809000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	1366000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	1437000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	96884000	USD
CY2013Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	96313000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	156228000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	156873000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	45115000	USD
CY2013Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	45161000	USD
CY2013Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15399000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14229000	USD
CY2012Q1	us-gaap	Legal Fees LegalFees	1011000	USD
CY2013Q1	us-gaap	Legal Fees LegalFees	209000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	472509000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	485405000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1082985000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1079507000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	97175000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	125214000	USD
CY2013Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1050000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1050000	USD
CY2013Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	224802000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	160802000	USD
CY2013Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CONMED Corporation (“CONMED”, the “Company”, “we” or “us”) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring.  The Company’s products are used by surgeons and physicians in a variety of specialties including </font><font style="font-family:inherit;font-size:10pt;">orthopedics, general surgery, gynecology, neurosurgery and gastroenterology</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	55816000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7634000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-70540000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4130000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7629000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5472000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	83889000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	86812000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15870000	USD
CY2013Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4256000	USD
CY2013Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1813000	USD
CY2012Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1988000	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	64325000	USD
CY2013Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	44442000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	86636000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61229000	USD
CY2013Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25732000	USD
CY2012Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	-1544000	USD
CY2013Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1636000	USD
CY2012Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2012Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17022000	USD
CY2012Q4	us-gaap	Other Assets OtherAssets	150547000	USD
CY2013Q1	us-gaap	Other Assets OtherAssets	151419000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-462000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-461000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	2127000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-1561000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2176000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1706000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6424000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4130000	USD
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16466000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14993000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	50000000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	64000000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7633000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5345000	USD
CY2012Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	809000	USD
CY2013Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1625000	USD
CY2012Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3696000	USD
CY2012Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3636000	USD
CY2013Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3431000	USD
CY2011Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3618000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1113000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1047000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	908000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1125000	USD
CY2012Q1	us-gaap	Profit Loss ProfitLoss	9968000	USD
CY2013Q1	us-gaap	Profit Loss ProfitLoss	10492000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	138411000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139041000	USD
CY2013Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2012Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	338000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5694000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7095000	USD
CY2013Q1	us-gaap	Restructuring Charges RestructuringCharges	1031000	USD
CY2013Q1	us-gaap	Restructuring Reserve RestructuringReserve	3607000	USD
CY2012Q4	us-gaap	Restructuring Reserve RestructuringReserve	4120000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	377907000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	384210000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	187014000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	194316000	USD
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	74806000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	77725000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1183000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1152000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	606998000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	597580000	USD
CY2013Q1	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	3455985	shares
CY2012Q4	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	2925801	shares
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	67963000	USD
CY2013Q1	us-gaap	Treasury Stock Value TreasuryStockValue	86045000	USD
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	373000	shares
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	455000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28484000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28500000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28127000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28029000	shares
CY2013Q1	cnmd	Excise Tax Medical ExciseTaxMedical	1580000	USD
CY2012Q1	cnmd	Excise Tax Medical ExciseTaxMedical	0	USD
CY2012Q4	cnmd	Goodwill As Reported GoodwillAsReported	256821000	USD
CY2012Q4	cnmd	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	278446000	USD
CY2013Q1	cnmd	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	278434000	USD
CY2013Q1	cnmd	Joint Development And Distribution Agreement Accumulated Amortization JointDevelopmentAndDistributionAgreementAccumulatedAmortization	7500000	USD
CY2012Q1	cnmd	Joint Development And Distribution Agreement Conditional Payment Amount JointDevelopmentAndDistributionAgreementConditionalPaymentAmount	84000000	USD
CY2013Q1	cnmd	Joint Development And Distribution Agreement Conditional Payment Amount Accrued JointDevelopmentAndDistributionAgreementConditionalPaymentAmountAccrued	50000000	USD
CY2012Q1	cnmd	Joint Development And Distribution Agreement Conditional Payment Period JointDevelopmentAndDistributionAgreementConditionalPaymentPeriod	P4Y
CY2013Q1	cnmd	Joint Development And Distribution Agreement Gross Carrying Amount JointDevelopmentAndDistributionAgreementGrossCarryingAmount	149400000	USD
CY2013Q1	cnmd	Joint Development And Distribution Agreement Term JointDevelopmentAndDistributionAgreementTerm	P25Y
CY2012Q1	cnmd	Joint Development And Distribution Agreement Up Front Payment JointDevelopmentAndDistributionAgreementUpFrontPayment	63000000	USD
CY2013Q1	cnmd	Payments For Contingent Payments PaymentsForContingentPayments	34000000	USD
CY2012Q1	cnmd	Payments For Contingent Payments PaymentsForContingentPayments	0	USD
CY2012Q1	cnmd	Payments Related To Distribution Agreement PaymentsRelatedToDistributionAgreement	64116000	USD
CY2013Q1	cnmd	Payments Related To Distribution Agreement PaymentsRelatedToDistributionAgreement	0	USD
CY2013Q1	cnmd	Product Liability Contingency Insurance Aggregate Annual Amount ProductLiabilityContingencyInsuranceAggregateAnnualAmount	25000000	USD
CY2013Q1	cnmd	Product Liability Contingency Insurance Amount Per Incident ProductLiabilityContingencyInsuranceAmountPerIncident	25000000	USD
CY2013Q1	cnmd	Product Warranty Accrual Term ProductWarrantyAccrualTerm	P1Y
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000816956
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27732070	shares
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	CONMED CORP

Files In Submission

Name	View Source	Status
0000816956-13-000006-index-headers.html	Edgar Link	pending
0000816956-13-000006-index.html	Edgar Link	pending
0000816956-13-000006.txt	Edgar Link	pending
0000816956-13-000006-xbrl.zip	Edgar Link	pending
cnmd-20130331.xml	Edgar Link	completed
cnmd-20130331.xsd	Edgar Link	pending
cnmd-20130331_cal.xml	Edgar Link	unprocessable
cnmd-20130331_def.xml	Edgar Link	unprocessable
cnmd-20130331_lab.xml	Edgar Link	unprocessable
cnmd-20130331_pre.xml	Edgar Link	unprocessable
cnmd3311310-q.htm	Edgar Link	pending
cnmd33113ex311.htm	Edgar Link	pending
cnmd33113ex312.htm	Edgar Link	pending
cnmd33113ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNMD
CONMED Corp Stock $cnmd

2013 Q1 Form 10-Q Financial Statement

#000081695613000006 Filed on April 29, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNMD CONMED Corp Stock $cnmd

2013 Q1 Form 10-Q Financial Statement

#000081695613000006 Filed on April 29, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNMD
CONMED Corp Stock $cnmd